Carlos Gómez-Martín

A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C

Bruno Sangro, Carlos Gómez-Martín, Manuel de la Mata et al. · Journal of Hepatology · 2013 · 988 citations

Medicine, Oncology, Pharmacology +15

Level of <i>HER2</i> Gene Amplification Predicts Response and Overall Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab

Carlos Gómez-Martín, Roberto Pazo-Cid, Antonieta Salud et al. · Journal of Clinical Oncology · 2013 · 196 citations · Full text

Medicine, Molecular Medicine, Oncology +15

Efficacy and Safety of Sorafenib in Combination With Mammalian Target of Rapamycin Inhibitors for Recurrent Hepatocellular Carcinoma After Liver Transplantation

Carlos Gómez-Martín, Javier Bustamante, J.F. Castroagudı́n et al. · Liver Transplantation · 2011 · 162 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death

Ramón Yarza, Mateo Bover, D. Paredes et al. · European Journal of Cancer · 2020 · 99 citations · Full text

Medicine, Infectious Diseases, Oncology +17

HER2/ <i>neu</i> testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer

Carlos Gómez-Martín, Elena Garralda, María José Echarri et al. · Journal of Clinical Pathology · 2012 · 92 citations · Full text

Medicine, Oncology, Gastrointestinal Oncology +13